Within a latest study, we reported the identification as well as the characterization of a new atypical opioid receptor with distinctive adverse regulatory Houses toward opioid peptides.1 Our outcomes confirmed that ACKR3/CXCR7, hitherto generally known as an atypical scavenger receptor for chem